FDA.reportPublic FDA data

terazosin 1 MG/mL Oral Solution

RxCUI
2689133
RxNorm name
terazosin 1 MG/mL Oral Solution
Display name
terazosin 1 MG/mL Oral Solution
Full name
terazosin 1 MG/mL Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TEZRULYTERAZOSINANI Pharmaceuticals, Inc.69582e0c-6569-490c-8c14-999f3750336f2025-04-18Warnings, Adverse reactionsExact identifier
rxcui: 2689133

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
69582e0c-6569-490c-8c14-999f3750336fterazosin 1 MG/mL Oral Solution [PSN] · terazosin 1 MG/ML Oral Solution [SCD] · terazosin 1 MG (equivalent to terazosin hydrochloride 1.1 MG) per ML Oral Solution [SY]33These highlights do not include all the information needed to use TEZRULY safely and effectively. See full prescribing information for TEZRULY. TEZRULY (terazosin) oral solution Initial U.S. Approval: 199320250418